Simulations Plus Basic Shares Outstanding 2010-2024 | SLP
Simulations Plus basic shares outstanding from 2010 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
Simulations Plus Annual Basic Shares Outstanding
(Millions of US $) |
| 2024 |
$20 |
| 2023 |
$20 |
| 2022 |
$20 |
| 2021 |
$20 |
| 2020 |
$18 |
| 2019 |
$17 |
| 2018 |
$17 |
| 2017 |
$17 |
| 2016 |
$17 |
| 2015 |
$17 |
| 2014 |
$16 |
| 2013 |
$16 |
| 2012 |
$16 |
| 2011 |
$16 |
| 2010 |
$16 |
| 2009 |
$16 |
Simulations Plus Quarterly Basic Shares Outstanding
(Millions of US $) |
| 2024-11-30 |
$20 |
| 2024-08-31 |
$20 |
| 2024-05-31 |
$20 |
| 2024-02-29 |
$20 |
| 2023-11-30 |
$20 |
| 2023-08-31 |
$20 |
| 2023-05-31 |
$20 |
| 2023-02-28 |
$20 |
| 2022-11-30 |
$20 |
| 2022-08-31 |
$20 |
| 2022-05-31 |
$20 |
| 2022-02-28 |
$20 |
| 2021-11-30 |
$20 |
| 2021-08-31 |
$20 |
| 2021-05-31 |
$20 |
| 2021-02-28 |
$20 |
| 2020-11-30 |
$20 |
| 2020-08-31 |
$18 |
| 2020-05-31 |
$18 |
| 2020-02-29 |
$18 |
| 2019-11-30 |
$18 |
| 2019-08-31 |
$17 |
| 2019-05-31 |
$18 |
| 2019-02-28 |
$17 |
| 2018-11-30 |
$17 |
| 2018-08-31 |
$17 |
| 2018-05-31 |
$17 |
| 2018-02-28 |
$17 |
| 2017-11-30 |
$17 |
| 2017-08-31 |
$17 |
| 2017-05-31 |
$17 |
| 2017-02-28 |
$17 |
| 2016-11-30 |
$17 |
| 2016-08-31 |
$17 |
| 2016-05-31 |
$17 |
| 2016-02-29 |
$17 |
| 2015-11-30 |
$17 |
| 2015-08-31 |
$17 |
| 2015-05-31 |
$17 |
| 2015-02-28 |
$17 |
| 2014-11-30 |
$17 |
| 2014-08-31 |
$16 |
| 2014-05-31 |
$16 |
| 2014-02-28 |
$16 |
| 2013-11-30 |
$16 |
| 2013-08-31 |
$16 |
| 2013-05-31 |
$16 |
| 2013-02-28 |
$16 |
| 2012-11-30 |
$16 |
| 2012-08-31 |
$16 |
| 2012-05-31 |
$16 |
| 2012-02-29 |
$16 |
| 2011-11-30 |
$16 |
| 2011-08-31 |
$19 |
| 2011-05-31 |
$15 |
| 2011-02-28 |
$15 |
| 2010-11-30 |
$16 |
| 2010-08-31 |
$16 |
| 2010-05-31 |
$16 |
| 2010-02-28 |
$16 |
| 2009-11-30 |
$16 |
| 2009-08-31 |
$20 |
| 2009-05-31 |
$16 |
| 2009-02-28 |
$16 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.624B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
